Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126203641 | 12620364 | 1 | I | 20160725 | 20160803 | 20160803 | EXP | GR-BAXTER-2016BAX040776 | BAXTER | 0.00 | F | Y | 0.00000 | 20160803 | MD | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126203641 | 12620364 | 1 | PS | ENDOXAN 1000 MG - POWDER FOR SOLUTION FOR INJECTION | CYCLOPHOSPHAMIDE | 1 | Unknown | REGIMEN #1 (FEC 100 X4), ADJUVANT SETTING | U | 12142 | POWDER FOR SOLUTION FOR INJECTION | /cycle | |||||||
| 126203641 | 12620364 | 2 | SS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Unknown | REGIMEN#1, ADJUVANT SETTING | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 3 | SS | epirubicin HCL | EPIRUBICIN HYDROCHLORIDE | 1 | Unknown | REGIMEN#1, FEC 100 X4, ADJUVANT SETTING | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 4 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | X4M, REGIMEN #1, ADJUVANT SETTING | U | 0 | 100 | MG/M**2 | /cycle | ||||||
| 126203641 | 12620364 | 5 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (1ST LINE) | U | 0 | /wk | ||||||||
| 126203641 | 12620364 | 6 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (3RD LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 7 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | REGIMEN #1, FEC 100 X4, ADJUVANT SETTING | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 8 | SS | leuprorelin | LEUPROLIDE ACETATE | 1 | Unknown | REGIMEN #1, ADJUVANT SETTING | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 9 | SS | leuprorelin | LEUPROLIDE ACETATE | 1 | Unknown | REGIMEN #1 (METASTATIC SETTING: 2ND LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 10 | SS | bevacizumab | BEVACIZUMAB | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (1ST LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 11 | SS | LETROZOLE. | LETROZOLE | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (2ND LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 12 | SS | zoledronic acid | ZOLEDRONIC ACID | 1 | Unknown | REGIMEN #1 (METASTATIC SETTING: 2ND LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 13 | SS | zoledronic acid | ZOLEDRONIC ACID | 1 | Unknown | REGIMEN #1 (METASTATIC SETTING: 4TH LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 14 | SS | everolimus | EVEROLIMUS | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (3RD LINE) | U | 0 | /cycle | ||||||||
| 126203641 | 12620364 | 15 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | REGIMEN #1, METASTATIC SETTING (4TH LINE) | U | 0 | 1250 | MG/M**2 | /cycle |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126203641 | 12620364 | 1 | Breast cancer |
| 126203641 | 12620364 | 2 | Breast cancer |
| 126203641 | 12620364 | 3 | Breast cancer |
| 126203641 | 12620364 | 4 | Breast cancer |
| 126203641 | 12620364 | 5 | Breast cancer |
| 126203641 | 12620364 | 6 | Breast cancer |
| 126203641 | 12620364 | 7 | Breast cancer |
| 126203641 | 12620364 | 8 | Breast cancer |
| 126203641 | 12620364 | 10 | Breast cancer |
| 126203641 | 12620364 | 11 | Breast cancer |
| 126203641 | 12620364 | 12 | Breast cancer |
| 126203641 | 12620364 | 14 | Breast cancer |
| 126203641 | 12620364 | 15 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126203641 | 12620364 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126203641 | 12620364 | Breast cancer metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |